|
|
|
|
|
| April 8 ,
2010 | ISSUE NUMBER 143 VOL 8 |
Strategy
Sanofi-Aventis Cuts 400 Jobs
Sales reps faced another round of layoffs last week as Sanofi-Aventis restructures its sales force due to looming generic competition and a dip in sales.
Approvals
Controlled-Release OxyContin Approved as Rx ODs Spike
FDA approves a new formulation of Purdue Pharma’s notoriously addictive opioid. This version is supposed to make it harder for the drug to be repurposed for nefarious consumption.
Opinion
Making Sense of US Health Reform: Some Points for the Perplexed
Some provisions of President Obama’s plan may encourage Pharma’s own worst tendencies.
New & Noteworthy
Ad Stars 2010
Pharm Exec presents the architects responsible for some of the year’s most memorable and innovative pharmaceutical advertisements.
Call for Nominations
Pharmaceutical Executive¹s Emerging Pharma Leadership Award
The pharma industry is facing some tough times‹and the old way of doing things just won¹t work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry‹through pure innovation‹to remake it for the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure that they get the recognition they deserve. Fill out your nomination today! |
|
 |
| 
|
 Sangamo BioSciences added Stephen Dilly to its board. // OncoGenex Pharmaceuticals appointed Jack Goldstein and H. Stewart Parker to its board. // PharmAthene hired Thomas Fuerst as its new chief scientific officer and upped Eric Richman to president and COO. // RRD International hired J. Scott Tarrant as its chief business officer. // Stratos Genomics added Heiner Dreismann to its board. He had been CEO of Roche Molecular Diagnostics. // AcelRx Pharmaceuticals appointed Richard King president and CEO. // Fibrocell Science added Marc Mazur to its board. // |
Bold Brands Drive Revenue with Storytelling
By: Brian Schrack, Product Manager and Greg Flessing, President Powerful stories captivate us every day. NCM Fathom explores how businesses can drive revenue and build loyalty sharing their brand’s story to compel audiences to change behavior and take action.
Download the whitepaper. |
The BIO International Convention Returns to Chicago!
Mark your calendars for the global event for biotechnology, May 3-6, 2010, at Chicago’s McCormick Place. Join more than 15,000 executives, investors, scientists, researchers, policy makers and journalists from around the world for strategic discussions, BIO Business Solutions® and new opportunities in biotech. Access the expert knowledge and resources you need to Heal, Fuel, Feed The World®. Visit convention.bio.org |
|
|
|
 |
|
 |
|
 |
| If you plan to enter emerging markets over the next 3 years, what will be your primary entry strategy? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
